Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
The "interpretation of result" section of the access toxo igm ii data sheet ref ds-14632a for the united states and ref ds-15806a for outside the united states incorrectly lists the reactive and the grey zone results. the access toxo igm ii ifu correctly lists the reactive and grey zone results and the system correctly reports the results.